1. Alfa Wassermann S.p.a. (21 from 64 patents)

2. Salix Pharmaceuticals, Inc. (3 from 63 patents)

3. Alfasigma S.p.a. (1 from 21 patents)

4. Manuela Campana (0 patent)

5. Goffredo Rosini (0 patent)

6. Vincenzo Cannata (0 patent)

7. Dario Braga (0 patent)

8. Donatella Confortini (0 patent)

9. Giuseppe C. Viscomi (0 patent)

10. Denis Severini (0 patent)

11. Paolo Righi (0 patent)

1. 10703763 - Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations

2. 9725466 - Rifaximin derivative and uses thereof

3. 9364467 - Rifaximin derivative and uses thereof

4. 9271968 - Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations

5. 9035046 - Rifaximin derivative and uses thereof

6. 8853231 - Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin

7. 8835452 - Polymorphic forms α, β and γ of rifaximin

8. 8765778 - Rifamycin derivatives

9. 8741904 - Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations

10. 8518949 - Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations

11. 8404704 - Use of polymorphic forms of rifaximin for medical preparations

12. 8318763 - Rifamycin derivatives

13. 8193196 - Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations

14. 8173801 - Processes for the production of polymorphic forms of rifaximin

15. 8158644 - Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin